SWMG
GSK icon

Signature Wealth Management Group’s GSK GSK Stock Holding History

Signature Wealth Management Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-66,162
Closed -$3.6M – 90
2022
Q2 		$3.6M Sell
66,162
-1,772
-3% -$97.8K 1.75% 26
2022
Q1 		$3.7M Buy
67,934
+5,323
+9% +$289K 1.67% 25
2021
Q4 		$3.45M Buy
62,611
+416
+0.7% +$21.6K 1.74% 25
2021
Q3 		$2.97M Sell
62,195
-907
-1% -$45.6K 1.65% 35
2021
Q2 		$3.14M Sell
63,102
-542
-0.9% -$26K 1.75% 34
2021
Q1 		$2.84M Sell
63,644
-507
-0.8% -$23K 1.67% 35
2020
Q4 		$2.95M Buy
64,151
+1,778
+3% +$81.7K 1.86% 26
2020
Q3 		$2.94M Buy
62,373
+935
+2% +$46.8K 2.11% 20
2020
Q2 		$3.13M Sell
61,438
-1,361
-2% -$69.8K 2.4% 14
2020
Q1 		$2.97M Sell
62,799
-483
-0.8% -$25.8K 2.61% 5
2019
Q4 		$3.72M Sell
63,282
-1,284
-2% -$71.4K 2.35% 10
2019
Q3 		$3.44M Buy
64,566
+85
+0.1% +$4.37K 2.28% 11
2019
Q2 		$3.29M Buy
64,481
+637
+1% +$32K 2.2% 19
2019
Q1 		$3.33M Buy
63,844
+552
+0.9% +$27.6K 2.34% 12
2018
Q4 		$3.02M Sell
63,292
-994
-2% -$49K 2.35% 15
2018
Q3 		$3.16M Buy
64,286
+5,480
+9% +$278K 2.34% 12
2018
Q2 		$2.96M Buy
58,806
+2,788
+5% +$140K 2.19% 19
2018
Q1 		$2.74M Buy
56,018
+5,582
+11% +$260K 2.11% 24
2017
Q4 		$2.24M Buy
+50,436
New +$2.33M 1.64% 32

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Signature Wealth Management Group's GSK Position: Q3 2022 in Review

Signature Wealth Management Group sold out of GSK (GSK) in Q3 2022, closing a stake of 66,162 shares — an estimated $3.6M sold.

Signature Wealth Management Group first reported a position in GSK in Q4 2017 and held it in 19 quarters. The position peaked at $3.72M in Q4 2019. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Signature Wealth Management Group reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Signature Wealth Management Group sold 66,162 GSK shares in Q3 2022, an estimated $3.6M.
  • Signature Wealth Management Group first reported a position in GSK in Q4 2017 and held it in 19 quarters.
  • Signature Wealth Management Group's GSK position peaked at $3.72M in Q4 2019.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Signature Wealth Management Group's 13F filing for Q3 2022, filed 2 Nov 2022.